Can anti-tumor necrosis factor agents be discontinued in patients with inflammatory bowel disease?

Jihye Park, Jae Hee Cheon

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)641-642
Number of pages2
JournalGut and liver
Volume15
Issue number5
DOIs
Publication statusPublished - 2021 Sep

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this